 immunoregul onchocerciasi function phenotyp abnorm lymphocyt subset chang therapi immunoregulatori defect patient onchocerciasi flow cytometr analysi lymphocyt subpopul parallel function assay signific differ ratio microfilariae-posit individu guatemala guatemalan control infect individu number lymphocyt control coexpress activ marker hla-dr cell infect individu contrast up-regul hla-dr cell year initi treatment semiannu dose microfilaricid ivermectin signific increas percentag cell percentag cell mitogen-induc lymphokin product chang parasite-specif product undetect treatment follow-up defect t-cell activ pathway onchocerca volvulus-infect individu sever independ point state parasit antigen-specif toler rel revers gener immunoregulatori defect